Prostate carcinoma
Item
newly diagnosed prostate cancer
boolean
C0600139 (UMLS CUI [1])
Examination With staging conventional Complete | Biopsy Associated with Gleason score | CT of abdomen | Computed Tomography (CT) of Pelvis | Bone scintigraphy Whole body | Examination With staging conventional Negative
Item
has completed conventional staging examinations, including biopsy with gleason score, ct scan of the abdomen and pelvis, and whole-body bone scintigraphy and conventional staging examinations negative
boolean
C0031809 (UMLS CUI [1,1])
C0332305 (UMLS CUI [1,2])
C0439858 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
C0005558 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C3203027 (UMLS CUI [2,3])
C0412620 (UMLS CUI [3])
C0412628 (UMLS CUI [4])
C3889015 (UMLS CUI [5,1])
C0444584 (UMLS CUI [5,2])
C0031809 (UMLS CUI [6,1])
C0332305 (UMLS CUI [6,2])
C0439858 (UMLS CUI [6,3])
C1513916 (UMLS CUI [6,4])
Indication Radical prostatectomy Curative | Indication Therapeutic radiology procedure Curative | Indication staging lymphadenectomy Before Operative Surgical Procedure
Item
candidate for curative radical prostatectomy or curative radiotherapy or staging lymphadenectomy prior to surgery
boolean
C3146298 (UMLS CUI [1,1])
C0194810 (UMLS CUI [1,2])
C1276305 (UMLS CUI [1,3])
C3146298 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C1276305 (UMLS CUI [2,3])
C3146298 (UMLS CUI [3,1])
C2019791 (UMLS CUI [3,2])
C0332152 (UMLS CUI [3,3])
C0543467 (UMLS CUI [3,4])
curative treatment Initial | Recurrence Intermediate Risk | Recurrence High risk
Item
deemed to be at medium or high risk for recurrence after initial curative treatment, as defined by 1 of the following criteria:
boolean
C1273390 (UMLS CUI [1,1])
C0205265 (UMLS CUI [1,2])
C2825055 (UMLS CUI [2,1])
C3640764 (UMLS CUI [2,2])
C2825055 (UMLS CUI [3,1])
C0332167 (UMLS CUI [3,2])
Gleason score | Prostate specific antigen measurement
Item
gleason score 7 and prostate-specific antigen (psa) 10-20 ng/ml
boolean
C3203027 (UMLS CUI [1])
C0201544 (UMLS CUI [2])
Gleason score | Prostate specific antigen measurement
Item
gleason score ≥ 8 and psa < 10 ng/ml
boolean
C3203027 (UMLS CUI [1])
C0201544 (UMLS CUI [2])
Gleason score | Prostate specific antigen measurement
Item
gleason score ≥ 8 and psa > 10 ng/ml
boolean
C3203027 (UMLS CUI [1])
C0201544 (UMLS CUI [2])
Gleason score | Prostate specific antigen measurement
Item
any gleason score and psa > 20 ng/ml
boolean
C3203027 (UMLS CUI [1])
C0201544 (UMLS CUI [2])
Exclusion Therapeutic procedure
Item
exclusion therapy:
boolean
C2828389 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Indication Operative Surgical Procedures | Indication Therapeutic radiology procedure Curative intent
Item
not a candidate for treatment by surgery or radiation therapy with curative intent
boolean
C3146298 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C1276305 (UMLS CUI [2,3])
Informed Consent Unable
Item
inability to give informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
invasive cancer | Skin carcinoma | Malignant Neoplasms Evidence of
Item
patients with other invasive malignancies, with the exception of non-melanoma skin cancer, who had (or have) any evidence of other cancer present within the last 5 years
boolean
C0677898 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0006826 (UMLS CUI [3,1])
C0332120 (UMLS CUI [3,2])